JPM 2020: The Impact of AI: How AI and ML are Transforming R&D and What's Next to Come

Written By Guest User

Monday, January 13
4:00–5:00 p.m.
Parc 55 San Francisco
Cyril Magnin Ballroom

Artificial Intelligence is significantly influencing global healthcare including drug development. This discussion will highlight how AI, and specifically, machine learning, is being used to: identify novel therapeutics; find, characterize and intervene on behalf of patients; integrate Social Determinants of Health (SDOH) and other data to provide new insights into patient care; and ultimately enable companies to work more efficiently and effectively. The panel will also explore trends and implications in partnering, business models and capital formation that impact the innovation and adoption of AI in healthcare. 

Guest User
Previous

AAIH Thought Leaders Publish Opinion Piece in The Hill
Next

AI Enabled IND & NDA - Special Inaugural Workshop